Skip to main content
Equibles
NHI logo

NHI · National Health Investors Inc

Track NHI — free

Use NHI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NHI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$72.95 +1.68 (+2.36%) At close · Aug 14
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Bickford has been a cash basis tenant since 2022 when we received financial information from Bickford raising substantial doubt about its ability to continue as a going concern. As of June 30, 2026, these concerns had not been alleviated.”
View the 10-Q filed Aug 10, 2026
Market Cap
$3.58B
Shares
49.11M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$72.95 Open$71.47 Day$71.47–73.54 52W close$68.32–91.02 Avg vol 30d398K Short int1.5M · 3.0% float · 3.7d Short vol70% Last earningsAug 11, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 14, 2026 Est · unconfirmed · in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 10, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Low
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −7%
      below
      Price vs 50-day avg −3%
      below
      RSI (14) 42
      neutral
      MACD trend Negative
      52-week position 20%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −8%
      trailing
      6-month return −19%
      trailing
      YTD return −4%
      this year
      Relative strength −33%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $75 › 200d $79 — 200d above 50d
      Institutional flow Distributing
      -6% holders QoQ · +41 funds added
      Insider flow Accumulating
      Net +$167.0K over 90 days · 0% sells
      Short interest Falling
      3.05% of float · ▼ -28.6% MoM · 3.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      299 holders — mid 3-yr range
      Squeeze score 51
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth +12%
      Y/Y
      EPS growth −4%
      Y/Y
      Free cash flow $-57.5M
      Valuation P/E 21.1
      below peers
      Buyback $500.0M
      authorized
      Balance sheet $1.1B
      net debt
      Quant / Vol
      risk profile
      Low
      Volatility 24%
      annualized · 1-yr
      Max drawdown −25%
      past year
      ATR 2.9%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 10, 2026
      NAREIT FFO per diluted share · 2026 full-year Initiated $4.74 – $4.79
      Normalized FFO per diluted share · 2026 full-year Initiated $4.74 – $4.79
      Same Store SHOP NOI growth on 15 properties · 2026 full-year Initiated 1% – 3%
      Total SHOP NOI on 42 properties, before the assumption for unide · 2026 full-year Initiated $44.1M – $45.1M
      Prior guidance period ended · from the 8-K filed Nov 6, 2025
      NAREIT FFO per diluted share · 2025 full year $4.62 – $4.65
      Normalized FFO per diluted share · 2025 full year $4.88 – $4.91
      Normalized FAD · 2025 full year $231.7M – $233.5M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      2 · 5 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −7% Bearish
      Price vs 50-day avg
      −3% Neutral
      RSI (14)
      42 Neutral
      MACD trend
      Negative Bearish
      52-week position
      20% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $75 › 200d $79 — 200d above 50d
      Institutional flow Distributing
      -6% holders QoQ · +41 funds added
      Insider flow Accumulating
      Net +$167.0K over 90 days · 0% sells
      Short interest Falling
      3.05% of float · ▼ -28.6% MoM · 3.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      299 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $68 Now $73 · 20% Range high $91
      vs 200-day avg -7% vs 50-day avg -3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      NAREIT FFO attributable to common stockholders non-GAAP $117.61M Six Months Ended June 30, 2026 —
      NAREIT FFO attributable to common stockholders per diluted share non-GAAP $2.42 Six Months Ended June 30, 2026 —
      Normalized FAD attributable to common stockholders non-GAAP $124.09M Six Months Ended June 30, 2026 —
      Normalized FFO attributable to common stockholders non-GAAP $117.61M Six Months Ended June 30, 2026 —
      Normalized FFO attributable to common stockholders per diluted share non-GAAP $2.42 Six Months Ended June 30, 2026 —
      Same Store properties NOI non-GAAP $6.59M Six Months Ended June 30, 2026 —
      SHOP invested capital $854.8M second quarter —
      first quarter invested capital $742.5M Q1 2026 —
      Net debt to Adjusted EBITDA non-GAAP 3.8 as of December 31, 2025 —
      Same Store SHOP NOI 13.09M the year ended December 31, 2025 —
      Senior Housing Operating Portfolio (SHOP) properties 26 the year ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      NHI
      National Health Investors Inc
      this stock
      		$3.58B -4.5% +12.1% 21.1 3.0%
      WELL
      Welltower Inc.
      		 $166.26B +26.9% +35.6% 117.2 2.5%
      VTR
      Ventas, Inc.
      		 $46.94B +18.3% +18.5% 169.5 4.6%
      DOC
      Healthpeak Properties, Inc.
      		 $14.34B +29.3% +4.5% 59.4 3.5%
      OHI
      Omega Healthcare Investors Inc
      		 $14.10B +4.9% +13.2% 16.6 4.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      299
      % held
      77.8%
      Net QoQ
      +3.6M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      274
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.5M
      Days to cover
      3.7d
      Change
      -599.1K sh
      View
      Short Volume
      Short vol %
      70%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      4
      Value
      $301
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      39.1%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$167.0K
      Buyers / Sellers
      2 / 0
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Gilbert Cisneros
      Amount
      $1.0K–$15.0K
      Traded
      Jan 15, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $375.6M
      Net income (FY)
      $142.2M
      EPS diluted
      $3.02
      View
      Buybacks
      Authorized
      $500.0M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 10, 2026
      This year
      23
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 11, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      NHI -3.1% -8.4% -19.0% -4.8% -4.5%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -3.5% -12.8% -32.7% -8.8% -18.3%

      Capital returns

      Latest dividend
      $0.92 / share · ex Jun 30, 2026
      Declared · upcoming
      $0.94 / share · ex Sep 30, 2026
      Raised 2.2%
      Paid (TTM)
      $3.68 / share · 4 payouts
      Dividend yield (TTM, derived)
      5.04%
      Buyback program · as of Jun 30, 2026
      Authorized
      $500.00M
      Spent (derived)
      —
      Remaining
      —

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 877860 CUSIP 63633D104 13F (30d) 287 filings 282 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)